Open AccessHyperhidrosis Comorbidities and Treatments: A Register-based Study among 511 Subjects
Author(s) -
Sanna-Liisa Heiskanen,
Jani Niskala,
Jari Jokelainen,
Kaisa Tasanen,
Laura Huilaja,
SuviPäivikki Sinikumpu
Publication year - 2022
Publication title -
acta dermato-venereologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.982
H-Index - 83
eISSN - 1651-2057
pISSN - 0001-5555
DOI - 10.2340/actadv.v102.1061
Subject(s) - hyperhidrosis , medicine , comorbidity , anxiety , psychosocial , dermatology , depression (economics) , epidemiology , quality of life (healthcare) , surgery , psychiatry , nursing , economics , macroeconomics
Hyperhidrosis is a dermatological condition that causes psychosocial impairment and has a negative impact on patients’ quality of life. The epidemiology of hyperhidrosis is currently poorly understood. The aim of this study was to analyse comorbidities and treatments in 511 subjects with hyperhidrosis selected from the patient records of Oulu University Hospital. The mean age of patients with local hyperhidrosis was 27.9 years and the majority were female (62.7%). The most common anatomical site of symptoms in the youngest age group was the palms, whereas the axillae were a more common site in advanced age. Depression was a common comorbidity in both local (11.6%) and generalized hyperhidrosis (28.6%). Anxiety affected 12.7% of patients with generalized hyperhidrosis. In 36.8% of the patients with local hyperhidrosis there was a delay in diagnosis of more than 10 years. The most commonly used treatments included topical antiperspirants, iontophoresis and botulin toxin injections.